chr9-14116328-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001190737.2(NFIB):āc.1264G>Cā(p.Val422Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00266 in 1,523,380 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0018 ( 0 hom., cov: 33)
Exomes š: 0.0028 ( 4 hom. )
Consequence
NFIB
NM_001190737.2 missense
NM_001190737.2 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 7.47
Genes affected
NFIB (HGNC:7785): (nuclear factor I B) Enables DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and transcription regulator inhibitor activity. Involved in brain development; negative regulation of DNA binding activity; and regulation of transcription by RNA polymerase II. Located in fibrillar center and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.01411134).
BP6
Variant 9-14116328-C-G is Benign according to our data. Variant chr9-14116328-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2499087.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 267 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00175 AC: 267AN: 152204Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
267
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00156 AC: 198AN: 126870Hom.: 0 AF XY: 0.00141 AC XY: 96AN XY: 67952
GnomAD3 exomes
AF:
AC:
198
AN:
126870
Hom.:
AF XY:
AC XY:
96
AN XY:
67952
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00276 AC: 3780AN: 1371058Hom.: 4 Cov.: 31 AF XY: 0.00259 AC XY: 1751AN XY: 674860
GnomAD4 exome
AF:
AC:
3780
AN:
1371058
Hom.:
Cov.:
31
AF XY:
AC XY:
1751
AN XY:
674860
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00175 AC: 267AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.00158 AC XY: 118AN XY: 74488
GnomAD4 genome
AF:
AC:
267
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
118
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
12
ALSPAC
AF:
AC:
17
ExAC
AF:
AC:
26
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
NFIB-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | NFIB: BS1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;.;.
REVEL
Benign
Sift
Benign
T;T;T;T;.;.
Sift4G
Benign
T;T;T;T;.;.
Vest4
MutPred
0.43
.;Loss of glycosylation at S419 (P = 0.1159);Loss of glycosylation at S419 (P = 0.1159);Loss of glycosylation at S419 (P = 0.1159);.;.;
MVP
MPC
1.1
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at